Post Event Demand Surge Nick Phin. Agenda  What is demand surge?  Why is it important?  What is our approach?  How can we use this framework?  What.

Slides:



Advertisements
Similar presentations
Remedy Statistics April 2009 May 28th 2009 Paris Desktop Support Analysis only done with Remedy tickets (Incident-Task-Request) (GRS requests are not included.
Advertisements

© 2008 Oracle Corporation – Proprietary and Confidential.
SEPTEMBER S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A LS T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L Panel Session:
© 2013 Sri U-Thong Limited. All rights reserved. This presentation has been prepared by Sri U-Thong Limited and its holding company (collectively, “Sri.
Pension Fund Trustees Liability Ncedi Mbongwe. Introduction to Camargue Underwriting Managers Established in 2001 Underwriters: Mutual and Federal and.
IMPORTANT READ CAREFULLY BEFORE USING THIS PRODUCT LICENSE AGREEMENT AND LIMITED WARRANTY BY INSTALLING OR USING THE SOFTWARE, FILES OR OTHER ELECTRONIC.
Hedge fund flows on pace to nearly double 2012
Irish recovery? Pär Magnusson
WisdomTree LargeCap Dividend Fund Performance Attribution
WisdomTree LargeCap Dividend Fund Performance Attribution September 2012.
Innovations in Structured Products October 25, 2010 An Innovator’s Dilemma?
13 September 2007] Vurdering af grunnfondsbeviset og grunnfondsbevisbankerne set fra London.
Mercer’s Climate Change Research 2011 to 2015
SARA IMG Event Johannesburg 10 April 2014 Changes in South African Immigration Law.
WisdomTree Emerging Markets Funds Performance Attribution December 2013.
FPGA and ASIC Technology Comparison - 1 © 2009 Xilinx, Inc. All Rights Reserved How do I Get Started with PlanAhead?
Client Update September 2013 Andrew Tasker – GFM Representative WA.
The contents of these materials are provided "as is" without any warranties of any kind and the Independent Electricity Market Operator (IMO) makes no.
MESSAGING IN THE MEDIA TOP 10 DRUGS BASED ON CREDIBILITY INDEX IN THE LITERATURE JOHN KNAPP, DIRECTOR OF ANALYTICS MAY 2009 Your use of these materials.
WisdomTree Emerging Markets Funds Performance Attribution March 2012.
Therapeutic area breakdown of lead projects in development for first launch in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM ©
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2014 by Standard.
Dunedin Enterprise Investment Trust PLC General Meeting – October 2013, Voting Analysis.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage Receipts.
S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L 1 [ PRESENTED AT THE ASIAN BANKER SUMMIT 2011 ] April 7, 2011 LIQUIDITY MANAGEMENT POST 2008.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage Supplier Returns.
Proportion of total R&D expenditure by therapeutic area in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS Your.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage and Disposition Inventory Returns.
Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output MARCH 2008 SOURCE: CMR INTERNATIONAL.
WisdomTree Emerging Markets Funds Performance Attribution June 2011.
2005/2006 Expenditure on biotech derived entities had remained constant APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
Number of pharmaceutical patent applications and granted patents for 5 major patent issuing authorities JUNE 2008 SOURCE: DERWENT WORLD PATENTS.
WisdomTree LargeCap Dividend Fund Performance Attribution March 2012.
Oracle E-Business Suite R12.1 Accounts Payables Partner Boot Camp Training Courseware Part VIII – Transaction Taxes in Payables.
Regulatory approval times between submission and marketing authorization approval APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.
Availability of High-Quality API for India, China and Rest of World MARCH 2008 David Harding, API Intelligence, Thomson Reuters Source: NEWPORT HORIZON.
1 of 26 For Oracle employees and authorized partners only. Do not distribute to third parties. © 2009 Oracle Corporation – Proprietary and Confidential.
Oracle E-Business Suite R12.1 Accounts Receivables Essentials Partner Boot Camp Training Courseware.
Allocation of R&D expenditure in 2005 between chemical entity and biological or biotech active substances APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Prepared by Aon Hewitt Retirement and Investment Consulting Presentation to Iowa School Districts Changes in Postemployment Benefit Accounting July 2015.
-1- For Oracle employees and authorized partners only. Do not distribute to third parties. © 2009 Oracle Corporation – Proprietary and Confidential Oracle.
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2011 Standard.
The secure site rendering issue (all navigation crushed together as a list at the top of the page) is a compatibility issue with Internet Explorer only.
Copyright © 2012, Oracle and/or its affiliates. All rights reserved. Oracle Proprietary and Confidential. 1.
WisdomTree LargeCap Dividend Fund Performance Attribution December 2011.
-1- For Oracle employees and authorized partners only. Do not distribute to third parties. © 2009 Oracle Corporation – Proprietary and Confidential Oracle.
Connectivity to bank and sample account structure
RaboDirect Financial Health Barometer 2016
Risks to the India Sugar Balance Sheet
Willis View of Risk A broker’s view
Post Event Demand Surge
BIOLOGY / CHEMISTRY CITATIONS GROWTH
Selecting the right provider
Under-rated assets in an over-priced world
Automation in an XML Authoring Environment
Mark Bennett, Head of Agribusiness, ANZ
Messaging in the Media TOP 10 AUDIENCES BY THERAPY AREA
, R&D expenditure showed 6% growth annually
Proportion of total R&D expenditure on alliances or joint ventures by stage of R&D in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.
% of the projects in development in the leading therapeutic areas were considered to have a novel mode of action APRIL 2007 SOURCE: CMR INTERNATIONAL.
Defensive Medicine Debate
Environmental Upgrade Finance
Motivation for 36OU Open Rack
Cycle times decreased in larger but not smaller, companies
Proportion of total R&D expenditure by function in 2005
DISCLAIMER This document contains information that is confidential and proprietary to SC Group. It is being given to you only for the purpose of review.
TITLE Source: Footnotes:. TITLE Source: Footnotes:
© 2013 Sri U-Thong Limited. All rights reserved
2019 MEDICARE AGE-IN STUDY SENIOR MARKET INSIGHTS SERVICE Part IV
Presentation transcript:

Post Event Demand Surge Nick Phin

Agenda  What is demand surge?  Why is it important?  What is our approach?  How can we use this framework?  What are some things to consider? 1 Proprietary & Confidential | 19 September, 2015 |

What is demand surge?  A component of post event loss amplification  Inflation in prices as a result of the increase in demand for resources relative to supply in the market  Demand > Supply  Inflated Prices  Examples of demand surge: –Cyclone Larry (~20-30%) –Hurricane Katrina (~40%) –Christchurch Earthquake?? –Victorian Bushfires?? 2 Proprietary & Confidential | 19 September, 2015 |

Why is it important to consider?  Impacts key stakeholders: –Policyholders –Shareholders –Management  Most models currently have limited capacity in dealing with demand surge  Ratings - S & P requires the inclusion of demand surge when calculating its cat risk capital charge  Regulatory requirements 3 Proprietary & Confidential | 19 September, 2015 |

Sources of demand surge  Labour  Materials  Plant  Location  Economy  Services 4 Proprietary & Confidential | 19 September, 2015 |

Our approach  Initial focus on NZ earthquake events and impact on Residential losses  Detailed ‘bottom up’ modular approach  Demand and supply of: –Labour occupations (e.g. plumber) –Materials (e.g. bricks)  Uses a time step process  Data sourced from EQC, Statistics NZ, Rawlinsons, Branz and RBNZ 5 Proprietary & Confidential | 19 September, 2015 |

Our approach 6 Proprietary & Confidential | 19 September, 2015 |

Hazard module – Damage states  Segmenting damaged properties  Distribution of dwellings at varying return periods 7 Proprietary & Confidential | 19 September, 2015 |

Labour module – House repair profile  Defines the sequence in which work is completed  Varies by damage state and construction type 8 Proprietary & Confidential | 19 September, 2015 |

Labour module – Time step process 9 Proprietary & Confidential | 19 September, 2015 |

Labour module – Supply from Regions  Labour is attracted to the event location as the supply of local labour is exhausted  Hierarchical inflow - Labour supply flows are defined via arrival and departure profiles 10 Proprietary & Confidential | 19 September, 2015 |

Materials module  Two material sources are assumed: –Domestic –Imported  Price and supply rates are controlled by: –Material stockpile –Pre-event material demand –Productivity rates  Linkage between labour and materials 11 Proprietary & Confidential | 19 September, 2015 |

Model outcomes 12 Proprietary & Confidential | 19 September, 2015 |

Other considerations  Allowances for commercial, industrial and infrastructure demands  Economic conditions –Economic cycle will affect labour supply –Currency fluctuations affect import price  Government intervention –Allocation of resources to high priority repairs –Caps on material prices 13 Proprietary & Confidential | 19 September, 2015 |

Darfield Earthquake  Currently collecting data to calibrate the model  Early Observations –The delay on reconstruction is considerable –Community spirit is key to cost mitigation –EQC management will be critical to demand surge mitigation –Resources are already arriving in Christchurch 14 Proprietary & Confidential | 19 September, 2015 |

Contacts  Please contact us if you would like further details to be included in this report: –Nick Phin+61 2 –Jaykishan Jeyendran –Andrew Hulme+61 2 –Ben Miliauskas Proprietary & Confidential | 19 September, 2015 |

Aon Benfield © Aon Benfield Australia Limited, trading as Aon Benfield (for itself and on behalf of each company within the Aon group of companies) reserves all rights to the content of this document. This document is provided exclusively for the use of the directors and employees of the organisation to which it was originally delivered. No part of this document may be reproduced or transmitted in any form or by any means, whether electronic or mechanical, including photocopying, recording or otherwise, without our prior written consent. Further copies for internal distribution are available on request for your own internal purposes, but no part of this document may be made available to any third party without both (i) Aon Benfield’s prior written consent and (ii) that third party having first signed a “recipient of report” letter in a form acceptable to us. Aon Benfield will accept no liability to any third party to whom this document is disclosed whether in compliance with the preceding sentence or otherwise. No responsibility is accepted to any third party for the whole or any part of the content of this document and all liability howsoever arising to any third party is hereby expressly excluded. This document does not constitute any form of legal, accounting, taxation regulatory or actuarial advice. Without prejudice to the generality of the preceding sentence this document does not constitute an opinion of reserving levels or accounting treatment. The recipient acknowledges that in preparing this document Aon Benfield may have based analysis on data provided by the recipient and/or from third party sources. This data may have been subjected to mathematical and/or empirical analysis and modelling. Aon Benfield has not verified, and accepts no responsibility for, the accuracy or completeness of any such data of the underlying information provided to it by its customer. In addition, the recipient acknowledges that any form of mathematical and/or empirical analysis and modelling (including that used in the preparation of this document) may produce results which differ from actual events or losses. Where this document includes a recommendation or an assessment of risk, the recipient acknowledges that such recommendation or assessment of risk is an expression of Aon Benfield’s opinion only and not a statement of fact. Any decision to rely upon any such recommendation or assessment will be solely at the risk of the recipient, for whom Aon Benfield accepts no liability, and the recipient acknowledges that this document does not replace the need for the recipient to make its own assessment. Aon Benfield will not be liable, in any event, for any special, indirect or consequential loss or damage of any kind (including, but not limited to, loss of profit and business interruption) arising from any use of the information contained in this document. The contents of this document are provided on an "as is" basis, and Aon Benfield expressly disclaims all warranties, whether express or implied, in respect of that content. We will not be liable, in any event, for any special, indirect or consequential loss or damage of any kind arising from any use of the information contained in this document. 16 Proprietary & Confidential | 19 September, 2015 |